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Abstract
Background: To assess the intra- and inter-rater agreement of chart abstractors from multiple
sites involved in the evaluation of an Asthma Care Program (ACP).
Methods: For intra-rater agreement, 110 charts randomly selected from 1,433 patients enrolled
in the ACP across eight Ontario communities were re-abstracted by 10 abstractors. For inter-rater
agreement, data abstractors reviewed a set of eight fictitious charts. Data abstraction involved
information pertaining to six categories: physical assessment, asthma control, spirometry, asthma
education, referral visits, and medication side effects. Percentage agreement and the kappa statistic
(κ) were used to measure agreement. Sensitivity and specificity estimates were calculated
comparing results from all raters against the gold standard.
Results: Intra-rater re-abstraction yielded an overall kappa of 0.81. Kappa values for the chart
abstraction categories were: physical assessment (κ 0.84), asthma control (κ 0.83), spirometry (κ
0.84), asthma education (κ 0.72), referral visits (κ 0.59) and medication side effects (κ 0.51). Inter-
rater abstraction of the fictitious charts produced an overall kappa of 0.75, sensitivity of 0.91 and
specificity of 0.89. Abstractors demonstrated agreement for physical assessment (κ 0.88, sensitivity
and specificity 0.95), asthma control (κ 0.68, sensitivity 0.89, specificity 0.85), referral visits (κ 0.77,
sensitivity 0.88, specificity 0.95), and asthma education (κ 0.49, sensitivity 0.87, specificity 0.77).
Conclusion: Though collected by multiple abstractors, the results show high sensitivity and
specificity and substantial to excellent inter- and intra-rater agreement, assuring confidence in the
use of chart abstraction for evaluating the ACP.
Background
Medical chart abstraction is a common method of data
collection in clinical and health care epidemiologic stud-
ies [1]. In a review of emergency medicine research arti-
cles, 244 of 986 primary studies (25%) relied on chart
reviews [2]. Beard et al also used more than 18,000 medi-
cal records to conduct a retrospective descriptive study of
asthma prevalence [3]. The extensive use of chart abstrac-
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and inter-rater reliability of the collected data, as it reflects
the quality of the data and the value of the results [4].
Although many investigators have expressed concern
regarding the reliability associated with data abstracted
from medical records [1,2,5,6], few studies report details
regarding the types of data elements that were assessed
and the methods used to ensure reliability [2,7-9]. For
multi-centre studies, the need for reliability assessments is
especially important given the involvement of multiple
data abstractors and the potential for variability. Thus,
designing a reliability assessment study that uses appro-
priate sampling techniques and analytic methods offers
an efficient way to verify the reliability of the data col-
lected through chart review. Indications of high agree-
ment can provide confidence in the data collection
process and the subsequent conclusions drawn from
those data [10].
Previous studies have assessed the reliability of medical
record reviews in the context of screening and the detec-
tion of adverse events [11,12]. This paper describes a sec-
ondary chart abstraction study carried out as part of the
multi-site Primary Care Asthma Pilot Project (PCAPP) to
determine the effectiveness of an evidence-based commu-
nity asthma care program. The purpose of chart re-abstrac-
tion was to measure the intra- and inter-rater reliability of
abstracted patient chart data across sites and assessors
involved in PCAPP.
Methods
Primary Care Asthma Pilot Project (PCAPP)
The Primary Care Asthma Pilot Project (PCAPP) was a
community-based participatory study funded by the
Ontario Ministry of Health and Long-Term Care. Initiated
in 2003, PCAPP was designed to determine whether the
use of an evidence-based Asthma Care Program (ACP)
would lead to improved asthma care delivery and out-
comes for patients from 15 satellite clinics in eight local
communities across Ontario. Patients included in PCAPP
were those aged 2 to 55 with mild to moderate asthma.
The satellite clinics included eight Community Health
Centres, a Rural Family Health Team, a Group Health
Centre and an Aboriginal Access Centre. Participants in
the PCAPP project consented to have their medical charts
reviewed on four occasions to measure the process of care
involved in the implementation of the ACP. Ten different
research staff conducted chart abstraction across the vari-
ous sites, thus it was essential to ensure that data were col-
lected consistently over time within each participating site
(intra-rater reliability) and across sites (inter-rater reliabil-
ity).
Initial data collection and reabstraction
The original chart extraction and coding of the 1,433
PCAPP participants' records occurred between September
2003 and June 2005. Information was abstracted on pro-
spective patient visits that took place at baseline, 6-month
follow-up, and 12-month follow-up to measure the proc-
ess of care during the implementation of the ACP. Infor-
mation was also abstracted from retrospective patient
visits that happened between January 1, 2002 and Decem-
ber 31, 2002 in order to describe the pattern of asthma
care prior to the ACP implementation. Data from patient
medical records were collected using a data abstraction
form containing 33 items grouped into six categories
(Table 1). Abstractors indicated on the form whether
information pertaining to each item was "documented"
or "not documented" in the patient's chart. The chart
abstraction study and the accompanying form were
approved by the Research Ethics Board at the Hospital for
Sick Children, Toronto.
In the current study, assessment of chart abstraction relia-
bility involved distinct methods of comparison for intra-
rater agreement and for inter-rater agreement. Intra-rater
agreement was based on the re-abstraction of medical
charts by abstractors from the same site at Time 2
(between July 2005 and February 2006) and comparing
the re-abstracted data to data collected at the initial
abstraction at Time 1 (between September 2003 and June
2005). To minimize the potential for recall and artificial
inflation of observed agreement, all data abstracted dur-
ing Time 1 (initial chart abstraction) were returned to the
research centre upon their completion, and chart abstrac-
tors were not granted access to their original responses at
Time 2 (chart re-abstraction). Inter-rater agreement
involved comparisons between abstractors and a gold
standard using a single set of eight fictitious medical
charts at the end of the study.
Definition of chart abstraction items
Six chart abstraction categories were used as a basis for
determining chart abstractor agreement: physical assess-
ment, asthma control, spirometry, asthma education,
referrals to specialists or education programs, and medica-
tions prescribed. The chart abstraction form included
space for abstractors to record specific medication infor-
mation. However, details such as generic/trade name,
strength, dosing, route of administration and duration
were considered especially challenging to analyze quanti-
tatively. Thus for the purpose of this study, only the pres-
ence of medication side effects was included as a
dichotomous yes/no variable for agreement analyses. A
summary of the number of chart abstraction items within
each category is shown in Table 1.Page 2 of 9
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As part of the main study, site coordinators and chart
abstractors took part in training workshops and orienta-
tion sessions to introduce the project and research meth-
odology to the local staff. Chart abstraction guides were
distributed to all sites and included abstraction proce-
dures, coding instructions, and several scenarios for dis-
cussion so that chart abstractors would handle potentially
challenging medical charts in a consistent manner. Addi-
tional site visits were conducted three to five months fol-
lowing the implementation of PCAPP to review data
collection processes and to ensure that research protocols
were being followed. Other ongoing communication
methods included email, teleconferencing, and regularly
scheduled Advisory Committee meetings.
Following abstraction, chart abstractors entered the data
into a database using Microsoft Access (Microsoft Corpo-
ration, Redmond, Washington). Data were transferred
monthly between the participating sites and the lead
investigating centre, where data were tracked and cleaned.
Assessing intra-rater reliability
To assess intra-rater reliability, ten abstractors re-abstracted
data at Time 2 from randomly selected patient charts that
had been abstracted at Time 1. A sample of 110 patient
charts representing 8% of the main study population was
randomly selected from the original sample for re-abstrac-
tion. Random number generation and subsequent analy-
ses were conducted using SAS Statistical Software version
9 [13]. The formula given by Sim and Wright [14], indi-
cated that the sample size for this re-abstraction study
would allow the detection of a kappa statistic between the
values 0.60 and 0.70 with 80% power at an alpha level of
0.05.
Assessing inter-rater reliability
To assess inter-rater agreement while ensuring that patient
charts remained in their respective sites to safeguard
patient confidentiality, an innovative method was used
wherein 8 fictitious medical charts were distributed to
each site chart abstractor as well as an experienced chart
abstractor who is not involved in the study. All abstractors
abstracted information from the eight simulated charts
using the study chart abstraction form. The simulated
charts reflected a range of patient characteristics: young
versus old, few versus multiple co-morbidities, controlled
versus uncontrolled asthma. Pilot testing of the fictitious
medical charts for face and content validity occurred at
two sites by individuals not involved in chart abstraction.
The set of charts underwent minimal revision. Examples
of the simulated patient chart and the chart abstraction
form are illustrated in Figure 1.
Table 1: Categories and items for chart abstraction
Categories and items
1. Physical assessment 4. Asthma education
1.1. Temperature 4.1. Review of asthma definition
1.2. Pulse 4.2. Provision of an asthma action plan
1.3. Respiratory rate 4.3. Verbal review of action plan
1.4. Blood pressure 4.4. Review of proper medication techniques
1.5. Height 4.5. Review of warning signs
1.6. Weight 4.6. Review of asthma triggers
1.7. Chest sounds 4.7. Review of control measures
1.8. Oxygen saturation 4.8. Management and coping strategies
2. Asthma control 5. Asthma referrals
2.1. Cough 5.1. Asthma education programs
2.2. Waking at night 5.2. Asthma support groups
2.3. Physical activity limitations 5.3. Specialists
2.4. Reliever use with exercise
2.5. Reliever use < 4 times per week
2.6. Exacerbations (hospital, ED visits)
2.7. School or work absenteeism
3. Spirometry 6. Medications
3.1. FEV1 pre-test 6.1. Side effects
3.2. FEV1 post-test
3.3. FEV1 % change
3.4. PEF pre-test
3.5. PEF post-test
3.6. PEF % change Total number of items = 33
Abbreviations: ED emergency department, FEV1 Forced Expiratory Volume in 1 second, PEF peak expiratory flowPage 3 of 9
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Intra-rater reliability was assessed using the overall per-
centage of agreement [15], and the kappa statistic. The
abstractors' responses given during the initial abstraction
(Time 1) were compared to those provided during the re-
abstraction (Time 2). To ensure proper comparison, the
abstracted data were matched by study identification
numbers and corresponding asthma-related visit dates.
Percentage agreement and the kappa statistic were also
used to assess inter-rater reliability across the study sites
for the eight simulated patient charts. Data abstractions
from the simulated charts by site abstractors were checked
against the data abstracted by the experienced chart
abstractor, who served as a gold standard. Sensitivity and
specificity estimates were calculated comparing results
from all raters against the gold standard.
Using the algorithm of Landis and Koch [16], kappa val-
ues of 0.80 and above represented excellent agreement,
values between 0.61 and 0.80 represented substantial
agreement, 0.41 to 0.61 represented moderate agreement,
and values below 0.40 suggested fair to poor agreement.
Summary kappa scores and percentage agreement were
calculated for each category (n = 6) and also for each var-
iable (n = 33). Agreement coefficients for each of the var-
iables were calculated to determine the range of
agreement within each category. The overall kappa score
was calculated by summation of scores within each cate-
gory, and subsequently using the category-specific kappa
values to compute an overall kappa summary statistic. The
homogeneity of kappas across chart abstraction categories




For the intra-rater component of the re-abstraction study,
110 charts were reviewed, and 218 documented asthma-
related patient visits were included in comparing chart
abstraction at Time 1 and Time 2.
Chart abstraction form and sample portion of a fictitious medical chart used for assessing inter-rater reliabilityFigure 1
Chart abstraction form and sample portion of a fictitious medical chart used for assessing inter-rater reliabil-
ity.Page 4 of 9
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statistics were 93% and 0.81 respectively. Across the six
categories, kappa varied between 0.51 and 0.84, with cat-
egories pertaining to asthma referrals and medication side
effects showing only moderate agreement. Table 2
presents a summary of the results for category-specific and
overall measures of agreement for intra-rater reliability.
Homogeneity testing of the category-specific kappa values
suggested statistically significant heterogeneity. It was
therefore of interest to explore possible sources of hetero-
geneity. Data were pooled and subsequently stratified by
abstractor to compare the degree of agreement between
Time 1 and Time 2 for each individual abstractor (Table
3). The abstractor-specific percentage agreement varied
from 79% to 98%, while the abstractor-specific intra-rater
kappa statistics ranged from 0.21 to 0.94. The heterogene-
ity chi-square statistic for the difference in the kappas cal-
culated for the 10 abstractors was also statistically
significant (χ2 = 238, p < 0.0001), suggesting that individ-
ual differences in abstractor consistency may account for
the heterogeneity of the overall category-specific kappa
values. Intra-rater agreement was also examined for all the
abstractors according to when the chart was abstracted,
either at the start of the study (on retrospective patient vis-
its prior to baseline) or at 6-month follow-up. The kappa
statistics were 0.76 (95% CI: 0.73, 0.79) for retrospec-
tively abstracted charts, and 0.82 (95% CI: 0.80, 0.85) for
6-month follow-up chart abstraction (data not shown in
tables).
Inter-rater agreement
As expected, inter-rater agreement measures were slightly
lower than those for intra-rater agreement. The overall
inter-rater percentage of agreement and kappa statistics
were 88% and 0.76 respectively (Table 4). Kappa values
showed moderate agreement for the category of asthma
education, and could not be calculated for the spirometry
and medication side effects categories due to a high
observed percentage of agreement. The overall sensitivity
and specificity estimates across all six categories were 0.91
and 0.89 respectively (Table 4), which indicate consistent
abstractions conducted by the raters in comparison to the
gold standard.
The inter-rater kappa values were shown to be statistically
heterogeneous according to the homogeneity test (χ2 =
737, p < 0.0001). To explore the source of heterogeneity,
data abstracted from the eight simulated charts were
pooled and agreement coefficients were calculated for
each paired combination of abstractors including the
standard abstractor who was not involved in the study.
The range of percentage agreement and kappa values are
shown in Figure 2. The percentage agreement across the
different pairs of abstractors ranged from 78% to 98%.
Kappa values ranged from 0.56 to 0.90 and were statisti-
cally heterogeneous (χ2 = 128 on 54 degrees of freedom,
p < 0.0001). Inter-rater agreement was then examined for
each simulated chart. As shown in Table 5, the percentage
agreement was consistent across the eight charts (85% to
91%), and kappa statistics ranged from 0.69 to 0.78. The
sensitivity estimates ranged from 0.84 to 0.99 and specif-
icity estimates ranged from 0.85 to 0.96.
Table 2: Category-specific and overall intra-rater reliability coefficients
Percentage agreement Kappa
Category (number of items) Category % % range across items Category κ 95% CI κ range across items
1. Physical assessment (8) 94 91–98 0.84 (0.81–0.87) 0.72–0.90
2. Asthma control (7) 92 85–95 0.83 (0.80–0.86) 0.60–0.88
3. Spirometry (6) 95 91–97 0.84 (0.80–0.86) 0.78–0.94
4. Asthma education (8) 91 78–95 0.72 (0.68–0.76) 0.55–0.82
5. Asthma referrals (3) 94 92–93 0.59 (0.46–0.71) 0.44–0.65
6. Medications (1) 94 94 0.51 (0.27–0.75) 0.51
Overall 93 0.81* (0.80–0.83)
* Chi-square test statistic for homogeneity = 47, df = 5, p < 0.0001
Abbreviations: κ kappa statistic, CI confidence interval
Table 3: Abstractor-specific intra-rater reliability coefficients
Kappa*
Abstractors Percentage agreement (%) κ 95% CI
1 88 0.21 (0.02–0.40)
2 85 0.71 (0.62–0.80)
3 91 0.79 (0.74–0.84)
4 94 0.83 (0.79–0.87)
5 96 0.89 (0.85–0.92)
6 94 0.78 (0.66–0.89)
7 93 0.78 (0.72–0.84)
8 79 0.57 (0.50–0.63)
9 88 0.66 (0.57–0.75)
10 98 0.94 (0.92–0.96)
* Chi-square test statistic for homogeneity = 238, df = 9, p < 0.0001
Abbreviations: κ kappa statistic, CI confidence intervalPage 5 of 9
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The results of this study showed that chart abstractors
involved in data collection for the Primary Care Asthma
Pilot Project reliably extracted information contained in
the medical charts. Previous studies of intra-rater and
inter-rater reliability have also demonstrated moderate to
substantial intra-rater and inter-rater reliability associated
with medical chart abstraction [6,18]. When abstracted by
the same rater, or raters within the same centre, the major-
ity of items (27 of 33, 82%) had kappa values greater than
0.61, suggesting that intra-rater agreement was substantial
to excellent overall as well as on a per-item basis despite
changes in staff that occurred at some sites. For inter-rater
agreement, 10 of 33 items (30%) were associated with a
kappa value greater than 0.61. Fewer items showed sub-
stantial inter-rater agreement as compared to intra-rater
agreement, which may be attributable to the content of
the fictitious charts used for inter-rater assessment rather
than differences in the abstraction process or between the
abstractors themselves.
Closer examination of the agreement coefficients revealed
differences in kappa statistics depending on the chart
abstraction category. For example, the kappa statistics
indicated only moderate agreement for intra-rater data
abstraction relating to asthma referrals and medication
side effects. Moderate agreement was also shown for inter-
rater data abstraction relating to asthma education. Infor-
mation pertaining to these abstraction categories was pre-
sented in the medical charts as free-text or in narrative
form. The demonstration of moderate agreement may be
due to differences in the abstractors' familiarity with the
concepts and terminology of asthma treatment strategies,
the indications for specialist referrals, and how and where
these details would be noted in the medical chart. Other
studies have identified similar issues as having a potential
impact on reliability [7,9,19]. Our findings showed that
intra-rater reliability was significantly improved for 6-
month follow-up chart abstraction compared to retro-
spective chart abstraction at baseline, which may be attrib-
utable to the effect of ongoing abstractor training and
increasing familiarization with the nuances of chart
abstraction over time.
A salient challenge of chart review is the accurate abstrac-
tion of medication information, dosing, frequency and
duration. Quantifying agreement for the documentation
of pharmaceutical treatments has important clinical
implications. This study was unable to analyse treatment
in this context. However, results showed moderate intra-
rater and inter-rater agreement for the categories of
asthma education, asthma referral, and medication side
effects, suggesting that agreement for more specific medi-
cation regimens may be moderate at best. Further studies
are needed to assess the agreement in medical chart docu-
mentation of treatments.
Results from this study also reflect the paradox associated
with the kappa statistic wherein an item or category dem-
onstrates high percentage agreement but a low kappa
coefficient [20]. This inherent limitation of kappa is well-
established and acknowledged. Thus, in some instances,
the percentage agreement may be a more appropriate
measure of reliability. In the presence of a reference or a
gold standard, test statistics such as sensitivity, specificity,
predictive values, and likelihood ratios are more often
used than the simple kappa statistic. In this study, since a
gold standard was available, it was possible to compute
sensitivity and specificity estimates across all the catego-
ries and for all the charts created. The overall sensitivity
and specificity measures in this study were in the order of
90% indicating good validity. Despite the limitations of
the kappa statistic, it was also used to present results of the
current study since it provides a simple measure to assess
intra-rater reliability (precision) and also inter-rater relia-
bility in studies that involve multiple raters. While there
Table 4: Category-specific and overall inter-rater reliability coefficients, sensitivity and specificity
Percentage agreement Kappa Sensitivity§ Specificity§
Category (number of 
items)
Category % % range across items Category κ 
(95% CI)




1. Physical assessment (8) 95 79–100 0.88 (0.87–0.90) 0.00–1.00 0.95 (0.92–0.97) 0.95 (0.91–0.98)
2. Asthma control (7) 84 76–93 0.68 (0.65–0.70) 0.05–0.71 0.89 (0.84–0.92) 0.85 (0.80–0.88)
3. Spirometry (6) 100 100 nc nc nc 0.99 (0.98–1.00)
4. Asthma education (8) 76 54–95 0.49 (0.46–0.52) 0.04–0.67 0.87 (0.80–0.92) 0.77 (0.73–0.81)
5. Asthma referrals (3) 90 88–93 0.77 (0.73–0.81) 0.02–0.84 0.88 (0.77–0.95) 0.95 (0.90–0.98)
6. Medications (1) 90 90 nc nc nc 0.94 (0.85–0.98)
Overall 88 0.75* (0.75–0.77) 0.91 (0.89–0.93) 0.89 (0.88–0.91)
* Chi-square test statistic for homogeneity = 737, df = 4, p < 0.0001
§ Sensitivity and specificity are calculated to compare assessments of all raters against the gold standard.
Abbreviations: κ kappa statistic, CI confidence interval, nc not calculablePage 6 of 9
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Ranges of inter-rater agreement among pairs of abstractorsFigure 2
Ranges of inter-rater agreement among pairs of abstractors. Data are shown as percentage agreement (%), kappa 
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Table 5: Simulated chart-specific inter-rater reliability coefficients
Kappa* Sensitivity§ Specificity§
Simulated Charts Percentage agreement (%) κ 95% CI Estimate 95% CI Estimate 95% CI
1 88 0.75 (0.72–0.78) 0.92 (0.86–0.96) 0.90 (0.85–0.94)
2 91 0.78 (0.75–0.82) 0.99 (0.91–1.00) 0.90 (0.85–0.93)
3 90 0.70 (0.66–0.74) 0.84 (0.73–0.91) 0.96 (0.92–0.98)
4 88 0.76 (0.73–0.79) 0.96 (0.90–0.99) 0.87 (0.82–0.91)
5 88 0.74 (0.71–0.78) 0.91 (0.82–0.96) 0.88 (0.83–0.92)
6 85 0.69 (0.65–0.73) 0.93 (0.85–0.97) 0.85 (0.79–0.90)
7 88 0.76 (0.73–0.79) 0.91 (0.85–0.95) 0.91 (0.85–0.95)
8 86 0.72 (0.69–0.76) 0.85 (0.77–0.90) 0.85 (0.79–0.90)
* Chi-square test statistic for homogeneity = 22, df = 7, p = 0.003
§ Sensitivity and specificity are calculated to compare assessments of all raters against the gold standard.
Abbreviations: κ kappa statistic, CI confidence interval
BMC Medical Research Methodology 2008, 8:29 http://www.biomedcentral.com/1471-2288/8/29are other methods of assessing interobserver agreement,
kappa remains by far the most commonly reported meas-
ure in the medical literature.
To address the objectives of this multi-site study, assessing
chart abstraction agreement required the computation of
multiple kappa statistics with the underlying assumption
that these individual measures could be combined statis-
tically into overall values for intra-rater reliability and
inter-rater reliability. The overall results indicated sub-
stantial to excellent agreement though statistical tests sug-
gested significant heterogeneity in the kappa statistics.
Further investigation of possible sources of heterogeneity,
including the clinical knowledge base of chart abstractors,
may be relevant to enhancing the design of studies involv-
ing clinical interventions that are documented and subse-
quently abstracted from patient medical charts.
Although the overall intra- and inter-rater agreement was
high in the current study, the reliability of chart abstrac-
tion data remained less than 100%. This means that there
may still be some misclassification during data collection,
which may result in a bias towards the null hypothesis
(Type II error) of the intervention study. One way to over-
come this potential problem is to obtain a large enough
sample size. Future evaluations of chart abstraction may
include regression modelling to investigate the heteroge-
neity in kappa statistics and the impact of possible explan-
atory factors on the probability of achieving agreement.
Methods such as the generalized estimating equation
(GEE) approach of Liang and Zeger [21] are considered
useful for intra-rater agreement involving clustered, multi-
centre designs where data are collected at multiple time
periods. Based on the elements involved in the current
study, possible covariates for investigation may include
the number of abstractors involved, the differences in
chart abstraction items or categories, and the duration of
time between abstractions.
Conclusion
This study demonstrates that chart abstraction can be a
reliable form of data collection in multi-centre studies for
asthma. The ongoing assessment of data reliability offers
an effective way of monitoring data quality, which can
subsequently improve the reliability of the results drawn
from the data.
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